e-learning
resources
Madrid 2019
Wednesday, 02.10.2019
Exacerbations of airway diseases
Login
Search all ERS
e-learning
resources
Disease Areas
Airways Diseases
Interstitial Lung Diseases
Respiratory Critical Care
Respiratory Infections
Paediatric Respiratory Diseases
Pulmonary Vascular Diseases
Sleep and Breathing Disorders
Thoracic Oncology
Events
International Congress
Courses
Webinars
Conferences
Research Seminars
Journal Clubs
Publications
Breathe
Monograph
ERJ
ERJ Open Research
ERR
European Lung White Book
Handbook Series
Guidelines
All ERS guidelines
e-learning
CME Online
Case reports
Short Videos
SpirXpert
Procedure Videos
CME tests
Reference Database of Respiratory Sounds
Radiology Image Challenge
Brief tobacco interventions
EU Projects
VALUE-Dx
ERN-LUNG
ECRAID
UNITE4TB
Disease Areas
Events
Publications
Guidelines
e-learning
EU Projects
Login
Search
Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom)
Source:
International Congress 2019 – Exacerbations of airway diseases
Session:
Exacerbations of airway diseases
Session type:
Poster Discussion
Number:
5223
Disease area:
Airway diseases
Rating:
You must
login
to grade this presentation.
Share or cite this content
Citations should be made in the following way:
M. Fahey (London, United Kingdom), W. Meeraus (London, United Kingdom), C. El Baou (London, United Kingdom), H. Mullerova (London, United Kingdom), E. M. Hessel (London, United Kingdom), W. A. Fahy (London, United Kingdom). Predicting early vs late vs no re-exacerbation in COPD patients:Analysis of ECLIPSE cohort. 5223
You must
login
to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
No comment yet.
You must
Login
to comment this presentation.
Related content which might interest you:
Panel discussion: Diagnostic tools for Obstructive Sleep Apnoea in adults and children
Expert interview: Physiological classification of lung function impairment
Occupational exposures to respiratory diseases: A case-based discussion
Related content which might interest you:
Factors associated with prolonged duration of AECOPD:Analysis of the ECLIPSE cohort
Source: International Congress 2019 – Airway disease-associated exacerbations
Year: 2019
Extent and impact of late vs early stage COPD diagnosis in the Swedish ARCTIC study
Source: International Congress 2016 – Screening, diagnosis, assessment, and treatment of COPD in primary care
Year: 2016
Markers of disease activity in COPD: an 8-year mortality study in the ECLIPSE cohort
Source: Eur Respir J, 57 (3) 2001339; 10.1183/13993003.01339-2020
Year: 2021
Frequency of exacerbations in patients with COPD: an analysis of the SPIROMICS cohort
Source: International Congress 2017 – COPD: latest insights into the management of patients
Year: 2017
Late Breaking Abstract - Relationship between clinical features and mortality in a cohort of COPD patients.
Source: Virtual Congress 2021 – Prediction of exacerbations in patients with COPD
Year: 2021
LATE-BREAKING ABSTRACT: Biomarkers of tissue turnover are related to annual change in FEV1 in patients with COPD within the ECLIPSE cohort
Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease
Year: 2015
Persistence of clinical criteria of chronic bronchitis in patients with COPD over time: A longitudinal analysis of the TRACE cohort.
Source: International Congress 2017 – Markers of COPD progression
Year: 2017
Characteristics, stability and outcomes of the 2011 GOLD COPD groups in the ECLIPSE cohort
Source: Eur Respir J 2013; 42: 636-646
Year: 2013
Identification of distinct trajectories of FEV1 progression in the ECLIPSE cohort
Source: Virtual Congress 2021 – Deep phenotyping of obstructive diseases for precision medicine
Year: 2021
Comparison of LAMA/LABA vs ICS/LABA in high risk COPD patients: Pre-specified analysis on lung function and health status from the IMPACT trial
Source: International Congress 2018 – COPD management
Year: 2018
REducing Delay through edUcation on eXacerbations (REDUX) in patients with COPD
Source: International Congress 2018 – Primary care management of COPD
Year: 2018
Late Breaking Abstract - Extrafine triple therapy reduces exacerbations in GOLD B COPD patients: post-hoc analysis of TRILOGY and TRINITY
Source: International Congress 2017 – Update and new perspectives in Airway Diseases
Year: 2017
Exacerbations in a cohort of COPD patients: frequent exacerbators characteristics after 1-year follow-up (EXACO study – interim analysis)
Source: Annual Congress 2008 - COPD - clinical and epidemiological aspects
Year: 2008
LATE-BREAKING ABSTRACT: Elevated cardiovascular risk as measured by QRISK2 score in patients hospitalized for acute COPD exacerbation
versus
stable COPD outpatients
Source: International Congress 2014 – Comorbidities
Year: 2014
Fatty liver infiltration in patients with COPD. An ECLIPSE cohort study
Source: International Congress 2016 – Imaging of COPD and airways: structural and functional assessments
Year: 2016
A comparison of COPD patients with and without ACOS in the ECLIPSE study
Source: Eur Respir J 2016; 47:1559-1562
Year: 2016
Late Breaking Abstract - Determinants of disease control in patients with severe COPD. The CLAVE Study
Source: International Congress 2019 – Clinical approach to asthma management
Year: 2019
Late Breaking Abstract - Analysis of the InforMing the PAthway of COPD Treatment (IMPACT) study in the subgroup of patients taking triple therapy at screening
Source: International Congress 2018 – COPD: from LABA/ICS to LABA/LAMA/ICS
Year: 2018
Characteristics of adult onset vs. late onset asthma - a multinational database cohort study
Source: International Congress 2017 – Asthma and ACOS: predictors and clinical characteristics
Year: 2017
Predictors of mortality in a well-characterised group of patients with COPD
Source: Annual Congress 2012 - COPD: epidemiology and varia
Year: 2012
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking "Accept", you consent to the use of the cookies.
Accept